参考文献/References:
[1] Mao XG, Xue XY, Wang L, et al. CDH5 is specifically acti-
vated in glioblastoma stemlike cells and contributes to
vasculogenic mimicry induced by hypoxia [J]. Neuro Oncol,
2013, 15(7): 865-879.
[2] Lamb J, Crawford ED, Peck D, et al. The Connectivity Map:
using gene-expression signatures to connect small mole-
cules, genes, and disease [J]. Science, 2006, 313(5795):
1929-1935.
[3] Mao XG, Guo G, Wang P, et al. Maintenance of critical pro-
perties of brain tumor stem-like cells after cryopreservation
[J]. Cell Mol Neurobiol, 2010, 30(5): 775-786.
[4] Mao XG, Zhang X, Xue XY, et al. Brain tumor stem-like
cells identified by neural stem cell marker CD15 [J]. Transl
Oncol, 2009, 2(4): 247-57.
[5] 张 芸,纪惜銮,臧爱民,等. 双嵌合抗原受体T细胞靶向
治疗恶性胶质瘤的实验研究[J]. 中国临床药理学杂志,
2018,34(14):1655-1658.
[6] Agnihotri S, Zadeh G. Metabolic reprogramming in glioblas-
toma: the influence of cancer metabolism on epigenetics
and unanswered questions [J]. Neuro Oncol, 2016, 18(2):
160-1672.
[7] Colwell N, Larion M, Giles AJ, et al. Hypoxia in the gliobla-
stoma microenvironment: shaping the phenotype of cancer
stem-like cells [J]. Neuro-oncology, 2017, 19(7): 887-896.
[8] Zong H, Parada LF, Baker SJ. Cell of origin for malignant
gliomas and its implication in therapeutic development [J].
Cold Spring Harb Perspect Biol, 2015, 7(5): 1-13.
[9] 陈石蕊,李金城,李子超,等. 缺氧与脑胶质细胞瘤的抗血
管治疗耐药机制[J]. 中华神经外科疾病研究杂志,2018,
17(4):376-378.
相似文献/References:
[1]谢宝树 张 林 王 宇 贾 锋 殷玉华.复发性多发胶质母细胞瘤的预后分析[J].中国临床神经外科杂志,2016,(06):333.[doi:10.13798/j.issn.1009-153X.2016.06.005]
XIE Bao-shu,ZHANG Lin,WANG Yu,et al.Analysis of prognoses in patients with recurrent multiple glioblastomas[J].,2016,(06):333.[doi:10.13798/j.issn.1009-153X.2016.06.005]
[2]黄书岚 成于思 王 辉 汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞
增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[3]彭泽生 田道锋 张申起 陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(06):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[4]李成林 丁 妍 于爱清 杨艳芳 李东升.CXCR4表达上调对U251细胞增殖、侵袭、迁移的影响[J].中国临床神经外科杂志,2016,(02):97.[doi:10.13798/j.issn.1009-153X.2016.02.013]
LI Cheng-lin,DING Yan,YU Ai-qing,et al.Effects of up-regulation of CXCR4 on proliferation, invasion and migration of U251 cells[J].,2016,(06):97.[doi:10.13798/j.issn.1009-153X.2016.02.013]
[5]宋贵东 综述 高之宪 审校.贝伐单抗治疗复发胶质母细胞瘤的研究进展[J].中国临床神经外科杂志,2015,(10):638.[doi:10.13798/j.issn.1009-153X.2015.10.022]
[6]李继强 杨吉安 邵灵敏 吴庭枫 刘宝辉 陈谦学.稳定低表达BAG3的胶质母细胞瘤U87细胞株的构建及鉴定[J].中国临床神经外科杂志,2015,(06):353.[doi:10.13798/j.issn.1009-153X.2015.06.011]
LI Ji-qiang,YANG Ji-an,SHAO Ling-min,et al.Construction and identification of U87 glioblastoma cell strain with a stable low expression of BAG3[J].,2015,(06):353.[doi:10.13798/j.issn.1009-153X.2015.06.011]
[7]丁 昊 周志伟 易 伟 雷 霆 简志宏 刘仁忠.LRIG1相关功能片段对EGFR活性和胶质瘤细胞增殖的影响[J].中国临床神经外科杂志,2015,(09):544.[doi:10.13798/j.issn.1009-153X.2015.09.011]
DING Hao,ZHOU Zhi-wei,YI Wei,et al.Effects of functional regions of LRIG1 on signaling of EGFR and cell proliferation of gliomas[J].,2015,(06):544.[doi:10.13798/j.issn.1009-153X.2015.09.011]
[8]宫崧峰 丁建军 汪 宇 苏 娟 王新军 王茂明 李维平 高永中.抑制Hedgehog信号通路对人脑胶质瘤肿瘤干细胞体外增殖的影响[J].中国临床神经外科杂志,2015,(02):96.[doi:10.13798/j.issn.1009-153X.2015.02.010]
GONG Song-feng,DING Jian-jun,WANG Yu,et al.Effect of intervention of Hedgehog signaling pathway on proliferation of human glioma stem cells in vitro[J].,2015,(06):96.[doi:10.13798/j.issn.1009-153X.2015.02.010]
[9]谈胤求 陈谦学 张红波 吴 鹏 李云涛 王栋良 袁凡恩.长链非编码RNA PVT1对人脑胶质瘤U251细胞增殖能力的影响[J].中国临床神经外科杂志,2016,(10):608.[doi:10.13798/j.issn.1009-153X.2016.10.013]
TAN Yin-qiu,CHEN Qian-xue,ZHANG Hong-bo,et al.Effect of lncRNA-PVT1 on proliferation of glioma U251 cells[J].,2016,(06):608.[doi:10.13798/j.issn.1009-153X.2016.10.013]
[10]韩铖琛,胡晨浩,杨帆,等.miRNA-145在脑胶质瘤中的作用[J].中国临床神经外科杂志,2017,(07):486.[doi:10.13798/j.issn.1009-153X.2017.07.013]
HAN Cheng-chen,HU Chen-hao,YANG Fan,et al.Effects of miRNA-145 on proliferation and apoptosis of U251 glioma cells[J].,2017,(06):486.[doi:10.13798/j.issn.1009-153X.2017.07.013]
[11]桂志勇 冯 军 黄俊红 白敬洋.靶向沉默c-fos基因表达对胶质瘤U87MG细胞增殖与侵袭的影响[J].中国临床神经外科杂志,2017,(12):834.[doi:10.13798/j.issn.1009-153X.2017.12.011]
GUI Zhi-yong,FENG Jun,HUANG Jun-hong,et al.Effects of c-fos targeted silence on proliferation and invasiveness of human glioma cell U87[J].,2017,(06):834.[doi:10.13798/j.issn.1009-153X.2017.12.011]
[12]胡克琦 周达全 陈 锋 周 毅 敖祥生.miR-153下调FOXR2、CDK8和CDK13的表达抑制胶质母细胞瘤细胞增殖[J].中国临床神经外科杂志,2020,(11):767.[doi:doi:10.13798/j.issn.1009-153X.2020.11.011]
HU Ke-qi,ZHOU Da-quan,CHEN Feng,et al.miR-153 inhibits proliferation of glioblastoma multiforme cell lines by down-regulation of FOXR2, CDK8 and CDK13[J].,2020,(06):767.[doi:doi:10.13798/j.issn.1009-153X.2020.11.011]
[13]王 鹏 刘邦鑫 张剑宁 陈金辉 常洪波 杨 晨.贝伐珠单抗联合高压氧治疗小鼠胶质母细胞瘤的效果[J].中国临床神经外科杂志,2021,26(09):696.[doi:10.13798/j.issn.1009-153X.2021.09.014]
WANG Peng,LIU Bang-xin,ZHANG Jian-ning,et al.Treatment of bevacizumab combined with hyperbaric oxygen therapy for a mouse model of glioblastoma[J].,2021,26(06):696.[doi:10.13798/j.issn.1009-153X.2021.09.014]
[14]冒平,王乙锠,王拓,等.下调TTK表达改善胶质母细胞瘤裸鼠的生存预后[J].中国临床神经外科杂志,2022,27(10):841.[doi:10.13798/j.issn.1009-153X.2022.10.013]
MAO Ping,WANG Yi-chang,WANG Tuo,et al.Down-regulation of TTK improves the survival prognoses of nude mice bearing intracranial glioblastoma xenografts[J].,2022,27(06):841.[doi:10.13798/j.issn.1009-153X.2022.10.013]
[15]麦麦提依明·托合提,张诚,黄啸元,等.上调miR-124-3p表达增加U-87 MG人胶质母细胞瘤细胞的放疗敏感性[J].中国临床神经外科杂志,2024,29(07):422.[doi:10.13798/j.issn.1009-153X.2024.07.008]
MAIMAITIYIMING Tuoheti,ZHANG Cheng,HUANG Xiao-yuan,et al.Upregulation of miR-124-3p expression increases the radiosensitivity of U-87 MG human glioblastoma cells[J].,2024,29(06):422.[doi:10.13798/j.issn.1009-153X.2024.07.008]